RN7SL551P

Across TCGA pan-cancer cohorts, RN7SL551P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL551P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RN7SL551P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL551P expression acts as an unfavorable survival marker, although some lineages such as KIRC and LIHC show a favorable association.

TGCT, KIRP, and MESO are the cancer types where RN7SL551P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	All	0.672	0.991	<.001	90	view →
KIRP	DFS	Tertile	IV	0.162	0.546	.009	54	view →
MESO	OS	Tertile	III,IV	0.036	0.563	<.001	54	view →
LUSC	DFS	Tertile	II,III,IV	0.148	0.673	.019	18	view →
KICH	DFS	Tertile	All	0.162	0.862	.014	15	view →
KIRC	OS	Tertile	All	0.745	0.600	.027	12	view →
ESCA	OS	Quartile	IV	0.127	0.569	.008	12	view →
CHOL	DFS	Tertile	All	0.093	0.434	.046	9	view →
LGG	DFS	Tertile	All	0.314	0.757	.020	9	view →
LIHC	DFS	Quartile	III,IV	0.399	0.117	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL551P–TGCT (OS)

Open the TGCT breakdown →